Cannabinoid Hyperemesis Syndrome: Literature Review
DOI:
https://doi.org/10.47611/jsrhs.v13i1.5945Keywords:
Cannabis, Hyperemesis, Vomiting, Youth, Adult, Cannabinoid, Syndrome, Cannabinoid Hyperemesis Syndrome, CHS, Nausea, Hot Shower ReliefAbstract
CHS is characterized by cyclic episodes of severe nausea, vomiting, and abdominal pain in individuals with a history of chronic cannabis use. Despite being paradoxical to the widely known antiemetic properties of cannabis, CHS continues to challenge healthcare professionals due to its often elusive diagnosis and mismanagement. The pathophysiology of CHS remains incompletely understood, but current research suggests that prolonged exposure to cannabinoids may disrupt the endocannabinoid system, resulting in dysregulated thermoregulation, gastrointestinal motility, and emesis. Additionally, genetic factors and individual variations in cannabis use patterns may contribute to the development of CHS. Diagnosis of CHS remains challenging, primarily based on clinical criteria, including a history of regular cannabis use, characteristic cyclic vomiting episodes, and symptom relief with hot showers or baths. Differential diagnosis must exclude other causes of cyclic vomiting, making CHS a diagnosis of exclusion. Management of CHS centers around discontinuing cannabis use, which typically leads to symptom resolution over time. Supportive care, including hydration and antiemetic medications, may be necessary during acute episodes. Capsaicin cream, a topical analgesic, has shown promise in alleviating symptoms in some cases. Behavioral therapy and substance abuse counseling may be essential to prevent relapse.
Downloads
References or Bibliography
Addiction | Health Effects | Marijuana | CDC. (2022, April 22). https://www.cdc.gov/marijuana/health-effects/addiction.html
Connor, J. P., Stjepanović, D., Budney, A. J., Le Foll, B., & Hall, W. D. (2022). Clinical management of cannabis withdrawal. Addiction (Abingdon, England), 117(7), 2075–2095. https://doi.org/10.1111/add.15743
Cordova, J., Biank, V., Black, E., & Leikin, J. (2021). Urinary Cannabis Metabolite Concentrations in Cannabis Hyperemesis Syndrome. Journal of Pediatric Gastroenterology & Nutrition, 73(4), 520–522. https://doi.org/10.1097/MPG.0000000000003220
Eleonore, D., & Denis, J. (2019). Cannabinoid Hyperemesis Syndrome: A Review of the Literature. Addiction Research and Adolescent Behaviour, 2(3), 01–04. https://doi.org/10.31579/2688-7517/013
ElSohly, M. A., Mehmedic, Z., Foster, S., Gon, C., Chandra, S., & Church, J. C. (2016). Changes in Cannabis Potency over the Last Two Decades (1995-2014)—Analysis of Current Data in the United States. Biological Psychiatry, 79(7), 613–619. https://doi.org/10.1016/j.biopsych.2016.01.004
Freeman, T. P., Craft, S., Wilson, J., Stylianou, S., ElSohly, M., Di Forti, M., & Lynskey, M. T. (2021). Changes in delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) concentrations in cannabis over time: Systematic review and meta-analysis. Addiction, 116(5), 1000–1010. https://doi.org/10.1111/add.15253
Galli, J. A., Sawaya, R. A., & Friedenberg, F. K. (2011a). Cannabinoid Hyperemesis Syndrome. Current Drug Abuse Reviews, 4(4), 241–249.
Galli, J. A., Sawaya, R. A., & Friedenberg, F. K. (2011b). Cannabinoid Hyperemesis Syndrome. Current Drug Abuse Reviews, 4(4), Article 4.
HALL, W., & DEGENHARDT, L. (2008). Cannabis use and the risk of developing a psychotic disorder. World Psychiatry, 7(2), 68–71.
Hernandez, J. M., Paty, J., & Price, I. M. (2018). Cannabinoid hyperemesis syndrome presentation to the emergency department: A two-year multicentre retrospective chart review in a major urban area. Canadian Journal of Emergency Medicine, 20(4), 550–555. https://doi.org/10.1017/cem.2017.381
Iacopetti, C. L., & Packer, C. D. (2014). Cannabinoid Hyperemesis Syndrome: A Case Report and Review of Pathophysiology. Clinical Medicine & Research, 12(1–2), 65–67. https://doi.org/10.3121/cmr.2013.1179
Lapoint, J., Meyer, S., Yu, C. K., Koenig, K. L., Lev, R., Thihalolipavan, S., Staats, K., & Kahn, C. A. (2018). Cannabinoid Hyperemesis Syndrome: Public Health Implications and a Novel Model Treatment Guideline. Western Journal of Emergency Medicine, 19(2), 380–386. https://doi.org/10.5811/westjem.2017.11.36368
Lua, J., Olney, L., & Isles, C. (2019). Cannabis Hyperemesis Syndrome: Still under Recognised after All These Years. Journal of the Royal College of Physicians of Edinburgh, 49(2), 132–134. https://doi.org/10.4997/jrcpe.2019.210
Ma, P. H., Joyce, K. M., Morton, T., Shih, D. W., Weiss, A., & Miller, J. (2021). A focused, longitudinal analysis of cannabinoid hyperemesis syndrome symptomatology. International Journal of Emergency Medicine, 14(1), 44. https://doi.org/10.1186/s12245-021-00367-4
MARIJUANA LEGALITY BY STATE - Updated Aug 1, 2023. (n.d.). DISA. Retrieved August 28, 2023, from https://disa.com/marijuana-legality-by-state
Myran, D. T., Roberts, R., Pugliese, M., Taljaard, M., Tanuseputro, P., & Pacula, R. L. (2022). Changes in Emergency Department Visits for Cannabis Hyperemesis Syndrome Following Recreational Cannabis Legalization and Subsequent Commercialization in Ontario, Canada. JAMA Network Open, 5(9), e2231937. https://doi.org/10.1001/jamanetworkopen.2022.31937
National Academies of Sciences, E., Division, H. and M., Practice, B. on P. H. and P. H., & Agenda, C. on the H. E. of M. A. E. R. and R. (2017). Therapeutic Effects of Cannabis and Cannabinoids. In The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research. National Academies Press (US). https://www.ncbi.nlm.nih.gov/books/NBK425767/
Nourbakhsh, M., Miller, A., Gofton, J., Jones, G., & Adeagbo, B. (2019). Cannabinoid Hyperemesis Syndrome: Reports of Fatal Cases. Journal of Forensic Sciences, 64(1), 270–274. https://doi.org/10.1111/1556-4029.13819
Osagie, E., & Mirza, O. (n.d.). Recurrent Severe Burns Due to Cannabinoid Hyperemesis Syndrome. Cureus, 15(2), e34552. https://doi.org/10.7759/cureus.34552
Perisetti, A. (2020). Cannabis hyperemesis syndrome: An update on the pathophysiology and management. Annals of Gastroenterology. https://doi.org/10.20524/aog.2020.0528
Perisetti, A., & Goyal, H. (2022). Endocannabinoid system and cannabis hyperemesis syndrome: A narrative update. European Journal of Gastroenterology & Hepatology, 34(1), 1–8. https://doi.org/10.1097/MEG.0000000000001992
Petrilli, K., Ofori, S., Hines, L., Taylor, G., Adams, S., & Freeman, T. P. (2022). Association of cannabis potency with mental ill health and addiction: A systematic review. The Lancet Psychiatry, 9(9), 736–750. https://doi.org/10.1016/S2215-0366(22)00161-4
Reinert, J. P., Niyamugabo, O., Harmon, K. S., & Fenn, N. E. (2021). Management of Pediatric Cannabinoid Hyperemesis Syndrome: A Review. The Journal of Pediatric Pharmacology and Therapeutics : JPPT, 26(4), 339–345. https://doi.org/10.5863/1551-6776-26.4.339
Rotella, J. A., Ferretti, O. G., Raisi, E., Seet, H. R., & Sarkar, S. (2022). Cannabinoid hyperemesis syndrome: A 6-year audit of adult presentations to an urban district hospital. Emergency Medicine Australasia, 34(4), 578–583. https://doi.org/10.1111/1742-6723.13944
Russo, E. B., Spooner, C., May, L., Leslie, R., & Whiteley, V. L. (2022). Cannabinoid Hyperemesis Syndrome Survey and Genomic Investigation. Cannabis and Cannabinoid Research, 7(3), 336–344. https://doi.org/10.1089/can.2021.0046
Sabbineni, M., Scott, W., Punia, K., Manuja, K., Singh, A., Campbell, K., MacKillop, J., & Balodis, I. (2023). Dopamine antagonists and topical capsaicin for cannabis hyperemesis syndrome ( CHS ) in the emergency department: A systematic review of direct evidence. Academic Emergency Medicine, acem.14770. https://doi.org/10.1111/acem.14770
Senderovich, H., Patel, P., Jimenez Lopez, B., & Waicus, S. (2022). A Systematic Review on Cannabis Hyperemesis Syndrome and Its Management Options. Medical Principles and Practice, 31(1), 29–38. https://doi.org/10.1159/000520417
Simonetto, D. A., Oxentenko, A. S., Herman, M. L., & Szostek, J. H. (2012). Cannabinoid hyperemesis: A case series of 98 patients. Mayo Clinic Proceedings, 87(2), 114–119. https://doi.org/10.1016/j.mayocp.2011.10.005
Sontineni, S. P., Chaudhary, S., Sontineni, V., & Lanspa, S. J. (2009). Cannabinoid hyperemesis syndrome: Clinical diagnosis of an underrecognised manifestation of chronic cannabis abuse. World Journal of Gastroenterology : WJG, 15(10), 1264–1266. https://doi.org/10.3748/wjg.15.1264
Sorensen, C. J., DeSanto, K., Borgelt, L., Phillips, K. T., & Monte, A. A. (2017). Cannabinoid Hyperemesis Syndrome: Diagnosis, Pathophysiology, and Treatment—a Systematic Review. Journal of Medical Toxicology, 13(1), 71–87. https://doi.org/10.1007/s13181-016-0595-z
Zhu, J. W., Gonsalves, C. L., Issenman, R. M., & Kam, A. J. (2021). Diagnosis and Acute Management of Adolescent Cannabinoid Hyperemesis Syndrome: A Systematic Review. The Journal of Adolescent Health: Official Publication of the Society for Adolescent Medicine, 68(2), 246–254. https://doi.org/10.1016/j.jadohealth.2020.07.035
Published
How to Cite
Issue
Section
Copyright (c) 2024 Avabella Mitrano; Maria Burgess
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Copyright holder(s) granted JSR a perpetual, non-exclusive license to distriute & display this article.
